 | Short Interest in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Declines By 26.3%
americanbankingnews.com - December 3 at 11:56 AM |
| 4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Up to $21.42
americanbankingnews.com - November 30 at 1:28 PM |
 | Insiders who placed huge bets on 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) earlier this year would be disappointed with the 6.9% drop
nasdaq.com - November 26 at 2:30 AM |
 | What You Need To Know About 4D Molecular Therapeutics, Inc.'s (NASDAQ:FDMT) Investor Composition
finance.yahoo.com - November 25 at 11:27 AM |
| 4D Molecular Therapeutics (NASDAQ:FDMT) Hits New 52-Week Low at $21.26
americanbankingnews.com - November 24 at 11:58 AM |
| 4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
finance.yahoo.com - November 23 at 8:22 PM |
| 4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $24.15
americanbankingnews.com - November 19 at 10:50 AM |
| 4D Molecular Therapeutics (NASDAQ:FDMT) Issues Quarterly Earnings Results
americanbankingnews.com - November 11 at 7:42 PM |
| 4D Molecular Therapeutics Reports Financial Results for the Third Quarter of 2021 and Provides Operational Highlights
finance.yahoo.com - November 10 at 4:44 PM |
| 4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - October 26 at 7:05 PM |
| 4D Molecular Therapeutics Reports Interim Results from the 4D-310 Phase 1/2 Clinical Trial in Patients with Fabry Disease and Provides Clinical Data Update from the 4D-110 Phase 1/2 Clinical Trial in Patients with Choroideremia
finance.yahoo.com - October 25 at 5:14 PM |
|
 | 4D Molecular Therapeutics Inc.
barrons.com - October 15 at 12:48 AM |
| 2 Catalysts That Could Move The Share Price Of 4D Molecular Therapeutics In Q4
nasdaq.com - October 12 at 2:16 PM |
| 4D Molecular (FDMT) to Start Studies on Cystic Fibrosis, Wet AMD
finance.yahoo.com - October 7 at 2:06 PM |
| 4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
finance.yahoo.com - September 29 at 6:51 PM |
| 4D Molecular Therapeutics Announces Late-Breaking Presentation of 4D-125 Clinical Data at the Upcoming ASRS Annual Meeting
finance.yahoo.com - September 24 at 11:39 AM |
| Is 4D Molecular Therapeutics, Inc. (FDMT) A Good Stock To Buy?
finance.yahoo.com - July 27 at 8:23 AM |
| Revenue Downgrade: Here's What Analysts Forecast For 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)
nasdaq.com - June 28 at 6:33 PM |
| Newsflash: 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - June 28 at 6:33 PM |
| 4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio Update, Including Initial Clinical Safety and Tolerability Data for 4D-110 for Choroideremia and 4D-125 for XLRP, and Termination of Roche Collaboration and License Agreement
finance.yahoo.com - June 24 at 8:18 AM |
| 4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer
finance.yahoo.com - June 7 at 9:40 AM |
| 4D Molecular Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
finance.yahoo.com - June 3 at 8:53 AM |
| 4D Molecular Therapeutics Reports Financial Results for the First Quarter of 2021 and Provides Operational Highlights
finance.yahoo.com - May 14 at 12:04 AM |
| 4D Molecular Therapeutics Presents Non-Human Primate Preclinical Data at ASGCT on the 4D-150 Product Candidate for wet AMD and DME
finance.yahoo.com - May 12 at 9:11 PM |
| 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Insiders Increased Their Holdings
finance.yahoo.com - May 10 at 4:00 PM |
| 4D Molecular Therapeutics Announces Collaboration on Leading Machine Learning Technology and Expertise from U.C. Berkeley to Expand Therapeutic Vector Evolution Platform
finance.yahoo.com - May 4 at 8:20 PM |
| 4D Molecular Therapeutics to Participate in BofA Securities 2021 Virtual Health Care Conference
finance.yahoo.com - April 30 at 9:29 AM |
| 4D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT and ATS Annual Meetings on Three Wholly-Owned Product Candidates from Non-Human Primate Studies
finance.yahoo.com - April 27 at 5:52 PM |
| Is FDMT Stock A Buy or Sell?
finance.yahoo.com - April 26 at 3:08 PM |
| What Kind Of Shareholders Hold The Majority In 4D Molecular Therapeutics, Inc.'s (NASDAQ:FDMT) Shares?
nasdaq.com - April 17 at 5:27 PM |
| 4D Molecular Therapeutics Reports Financial Results for the Year Ended December 31, 2020 and Provides Operational Highlights
finance.yahoo.com - March 25 at 6:10 PM |
| We Think 4D Molecular Therapeutics (NASDAQ:FDMT) Can Afford To Drive Business Growth
finance.yahoo.com - March 11 at 8:12 AM |
 | Genetic Modification Therapies Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030
marketwatch.com - March 11 at 1:08 AM |
| 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-310 for the Treatment of Fabry Disease
finance.yahoo.com - March 9 at 9:09 AM |
| 4D Molecular Therapeutics, Inc. Common Stock (FDMT)
nasdaq.com - January 31 at 12:42 AM |
| BioAtla Is the Latest Biotech IPO to Pop
finance.yahoo.com - December 16 at 6:39 PM |
